Carestream, Philips, Sectra and 5 more industry names in the news of late

GE Healthcare debuts all-digital PET/CT system, Omni Legend (Oct. 16).

Konica Minolta Healthcare Americas celebrates Emory Healthcare researcher for winning two awards with the company’s AI analysis tool for diagnosing shoulder injury on digital radiography (Oct. 14).

Philips markets ClarifEye augmented reality surgical navigation in Japan (Oct. 13).

ANregiomed healthcare network of Ansbach, Germany, taps imaging IT and cybersecurity company Sectra (Linköping, Sweden) for enterprise imaging software and services (Oct. 12).

Aftermarket parts and service supplier DirectMed (San Diego) acquires MRI coil vendor ScanMed of Omaha, Neb. (Oct. 11).

Medical isotope specialists Eckert & Ziegler (Berlin, Germany) building Actinium-225 production line for nuclear medicine supplier NorthStar Medical Radioisotopes of Beloit, Wis. (Oct. 11).

Market research and analysis firm Brandon Hall Group of Delray Beach, Fla., recognizes Carestream Health (Rochester, N.Y.) for excellence in leadership development (Oct. 11).

FDA releases final guidance documents on device post-approval studies and postmarket device surveillance (Oct. 7).

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.